GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Extendicare Inc (OTCPK:EXETF) » Definitions » Graham Number

Extendicare (Extendicare) Graham Number : $N/A (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Extendicare Graham Number?

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2024-04-29), the stock price of Extendicare is $5.335. Extendicare's graham number for the quarter that ended in Dec. 2023 was $N/A. Therefore, Extendicare's Price to Graham Number ratio for today is N/A.

The historical rank and industry rank for Extendicare's Graham Number or its related term are showing as below:

During the past 13 years, the highest Price to Graham Number ratio of Extendicare was 28.52. The lowest was 2.93. And the median was 5.15.

EXETF's Price-to-Graham-Number is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.075
* Ranked among companies with meaningful Price-to-Graham-Number only.

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Extendicare Graham Number Historical Data

The historical data trend for Extendicare's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extendicare Graham Number Chart

Extendicare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Graham Number
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 1.77 0.52 0.17 -

Extendicare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.19 - - -

Competitive Comparison of Extendicare's Graham Number

For the Medical Care Facilities subindustry, Extendicare's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Extendicare's Price-to-Graham-Number Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Extendicare's Price-to-Graham-Number falls into.



Extendicare Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Extendicare's Graham Number for the fiscal year that ended in Dec. 2023 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*-0.326*0.314)
=N/A

Extendicare's Graham Number for the quarter that ended in Dec. 2023 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*-0.326*0.324)
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Extendicare  (OTCPK:EXETF) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Extendicare's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Dec. 2023 )
=5.335/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Extendicare Graham Number Related Terms

Thank you for viewing the detailed overview of Extendicare's Graham Number provided by GuruFocus.com. Please click on the following links to see related term pages.


Extendicare (Extendicare) Business Description

Traded in Other Exchanges
Address
3000 Steeles Avenue East, Suite 700, Markham, ON, CAN, L3R 9W2
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The company has three main business segments namely Long-term Care, Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides more than 9 million hours of home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada.

Extendicare (Extendicare) Headlines

From GuruFocus

Extendicare Provides Business Update Related to COVID-19

By GlobeNewswire GlobeNewswire 04-28-2020

Extendicare Completes Acquisition of Lynde Creek Retirement Community

By GlobeNewswire GlobeNewswire 04-11-2018

Extendicare Appoints Dr. Michael R. Guerriere as New President and CEO

By GlobeNewswire GlobeNewswire 09-11-2018

Extendicare Announces December 2019 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-12-2019

Extendicare Announces Normal Course Issuer Bid

By GlobeNewswire GlobeNewswire 06-27-2022

Extendicare Announces 2020 First Quarter Results

By GlobeNewswire GlobeNewswire 05-14-2020